Published on October 28, 2009 at 7:40 AM
Arrayit Corporation (OTCBB: ARYC) today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.
"We are very excited to have CENAT as a customer for our NanoPrint enterprise level microarray robot," stated Rene Schena, CEO and Chairman of Arrayit. "This relationship demonstrates the commercial value of our core technology for cancer research and diagnostics."
"The Arrayit microarray manufacturing platform will help accelerate on-going myeloid leukemia cancer analysis at CENAT," stated Dr. Luiza Handschuh, CENAT Laboratory Director. "Arrayit's system offers us the ability to make high quality microarrays of all types that will greatly enhance cancer research by enabling quantitative DNA, RNA and protein analysis."
Versatile NanoPrint microarrayers have also been installed at other major research and diagnostics centers including Harvard University in Massachusetts, Sandia National Laboratories in New Mexico, Scripps Research Institute in Florida, The Biodesign Institute in Arizona, and Mount Sinai School of Medicine in New York City.
SOURCE: Arrayit Corporation